Analyze Diet

Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease.

Abstract: Gastrointestinal disorders, especially strangulating intestinal obstructions, are still a major cause of illness and death in the horse. Circulating lipopolysaccharides may activate both neutrophils and monocytes. The activated neutrophils release myeloperoxidase (MPO), a specific enzyme with strong oxidative activity. The aim of this study was to evaluate MPO concentrations in the plasma and peritoneal fluid (PF) of horses with colic and to check the hypothesis that these concentrations would be higher in a case of strangulating obstruction than in cases of nonstrangulating disease. By using a specific enzyme-linked immunosorbent assay for equine MPO, we determined the MPO concentrations in horses admitted to a clinic for colic. Horses with nonstrangulating or strangulating obstruction of the large intestine (NSLI or SLI), strangulating obstruction of the small intestine (SSI), or inflammatory bowel disease (IBD) were compared with healthy horses. The horses with SLI, SSI, or IBD had significantly higher MPO levels in plasma and PF than did those in the other 2 groups. The mean plasma level was significantly higher in the horses with NSLI than in the healthy horses. High MPO values in PF indicated necrotic bowel. These results show that neutrophil activation occurs during nonstrangulating and strangulating intestinal obstruction in horses and that the plasma and PF MPO concentrations may be a marker of the severity of the disease. Les pathologies intestinales du cheval, en particulier les obstructions étranglées, sont toujours une cause majeure de morbidité et de mortalité chez le cheval. A côté de l’activation des monocytes via les lipopolysaccharides, une activation des neutrophiles se produit également. Le neutrophile activé relargue la myéloperoxidase (MPO), une enzyme spécifique qui a une activité oxidative puissante. Le but de l’étude est d’évaluer le taux de MPO du plasma et du liquide péritonéal chez des chevaux en coliques à l’admission. L’hypothèse est que les taux de MPO sont plus importants en cas d’obstruction étranglée par rapport à l’obstruction simple. En utilisant un test de dosage immunoenzymatique spécifique de la MPO équine, les auteurs ont déterminé les taux de MPO dans le plasma et le liquide péritonéal des chevaux admis pour colique en clinique. Quatre groupes de chevaux ont été étudiés et comparés aux chevaux sains : des chevaux avec obstruction non-étranglée ou étranglée du gros intestin, obstruction étranglée de l’intestin grêle, et pathologie intestinale de type inflammatoire. Les chevaux avec pathologie étranglée et inflammatoire présentent des taux de MPO du plasma et du liquide péritonéal significativement plus élevés que les chevaux avec pathologie non-étranglée et les sains. Les valeurs de MPO plasmatique sont significativement plus élevées chez les chevaux avec pathologie non-étranglée par rapport aux chevaux sains. Des valeurs élevées de MPO dans le liquide péritonéal sont des indices de nécrose intestinale. Ces résultats montrent l’existence d’une activation des neutrophiles lors des pathologies intestinales étranglées et non-étranglées chez le cheval. La concentration de MPO dans le plasma et le liquide péritonéal peut être un indicateur de la gravité de la pathologie intestinale chez le cheval. (Traduit par les auteurs)
Publication Date: 2008-01-25 PubMed ID: 18214160PubMed Central: PMC2117365
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the concentration levels of myeloperoxidase (MPO) enzyme in the blood and peritoneal fluid of horses suffering from colic, aiming to investigate if these levels increase in cases of intestinal obstruction. It concludes that MPO concentrations can be used to indicate the severity of the disease.

Objective of the Research

  • The primary goal of this research was to examine the concentration levels of Myeloperoxidase (MPO) enzyme in the blood and peritoneal fluid of horses that are suffering from colic.
  • The study also aimed to test if these levels were higher in strangulating obstruction, a severe form of the disease, compared to non-strangulating disease states.
  • The potential of MPO concentrations as a biomarker for assessing the severity of the disease was also investigated.

Methodology of the Research

  • The study involved comparing horses with different conditions: nonstrangulating obstruction of the large intestine (NSLI), strangulating obstruction of the large intestine (SLI), strangulating obstruction of the small intestine (SSI), inflammatory bowel disease (IBD), and healthy horses.
  • A specific enzyme-linked immunosorbent assay was utilized to measure the levels of MPO.

Findings of the Research

  • The findings indicated that MPO levels in plasma and peritoneal fluid were significantly higher in horses suffering from SLI, SSI, or IBD compared to the other groups.
  • Moreover, horses with NSLI had a significantly higher mean plasma level of MPO than the healthy horses.
  • High MPO values in the peritoneal fluid were found to suggest necrotic bowel, a severe condition of tissue death due to inadequate blood supply.

Conclusion of the Research

  • The results demonstrated neutrophil activation in both nonstrangulating and strangulating intestinal obstruction in horses.
  • MPO concentrations in the plasma and peritoneal fluid, thus, may serve as a marker to indicate the severity of the disease, providing healthcare professionals a potential diagnostic tool.

Cite This Article

APA
Grulke S, Franck T, Gangl M, Péters F, Salciccia A, Deby-Dupont G, Serteyn D. (2008). Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease. Can J Vet Res, 72(1), 37-42.

Publication

ISSN: 0830-9000
NlmUniqueID: 8607793
Country: Canada
Language: English
Volume: 72
Issue: 1
Pages: 37-42

Researcher Affiliations

Grulke, Sigrid
  • Clinique Equine, Anesthésiologie et Pathologie chirurgicale, Faculté de médecine vétérinaire B 41, Université de Liège, Sart Tilman, B-4000 Liège, Belgium. sgrulke@ulg.ac.be
Franck, Thierry
    Gangl, Monika
      Péters, Fabrice
        Salciccia, Alexandra
          Deby-Dupont, Ginette
            Serteyn, Didier

              MeSH Terms

              • Animals
              • Ascitic Fluid / enzymology
              • Biomarkers / analysis
              • Biomarkers / blood
              • Case-Control Studies
              • Colic / blood
              • Colic / enzymology
              • Colic / veterinary
              • Female
              • Gastrointestinal Diseases / blood
              • Gastrointestinal Diseases / enzymology
              • Gastrointestinal Diseases / veterinary
              • Horse Diseases / blood
              • Horse Diseases / enzymology
              • Horses
              • Inflammatory Bowel Diseases / blood
              • Inflammatory Bowel Diseases / enzymology
              • Inflammatory Bowel Diseases / veterinary
              • Intestinal Obstruction / blood
              • Intestinal Obstruction / enzymology
              • Intestinal Obstruction / veterinary
              • Male
              • Neutrophil Activation
              • Neutrophils / enzymology
              • Peroxidase / analysis
              • Peroxidase / blood
              • Severity of Illness Index

              References

              This article includes 27 references
              1. Cohen ND, Matejka PL, Honnas CM, Hooper RN. Case–control study of the association between various management factors and development of colic in horses. J Am Vet Med Assoc 1995;206:667–673.
                pubmed: 7744689
              2. Tinker MK, White NA, Lessard P. Prospective study of equine colic risk factors. Equine Vet J 1997;29:454–458.
                pubmed: 9413718
              3. Moore JN, White NA, Berg JN, Trim CM, Garner HE. Endotoxemia following experimental intestinal strangulation obstruction in ponies. Can J Comp Med 1981;45:330–332.
                pmc: PMC1320229pubmed: 7200383
              4. King J, Gerring E. Detection of endotoxin in cases of equine colic. Vet Rec 1988;123:269–271.
                pubmed: 3188348
              5. Benbarek H, Deby-Dupont G, Caudron I. Interaction between lipopolysaccharides and blood factors on the stimulation of equine polymorphonuclear neutrophils. Vet Immunol Immunopathol 1998;64:313–322.
                pubmed: 9764724
              6. Dagleish MR, Brazil TJ, Scudamore CL. Potentiation of the extracellular release of equine neutrophil elastase and alpha-1-proteinase inhibitor by a combination of two bacterial cell wall components: fMLP and LPS. Equine Vet J 2003;35:35–39.
                pubmed: 12553460
              7. Moore RM, Bertone AL, Bailey MQ, Muir WW, Beard WL. Neutrophil accumulation in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res 1994;55:454–463.
                pubmed: 7998704
              8. Partrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC. Neutrophil priming and activation in the pathogenesis of post-injury multiple organ failure. New Horiz 1996;4:194–210.
                pubmed: 8774796
              9. Deby-Dupont G, Deby C, Lamy M. Neutrophil myeloperoxidase revisited: its role in health and disease. Intensivmed Notfallmed 1999;36:500–513.
              10. Hoy A, Leininger-Muller B, Kutter D, Siest G, Visvikis S. Growing significance of myeloperoxidase in non-infectious diseases. Clin Chem Lab Med 2002;40:2–8.
                pubmed: 11916266
              11. McConnico RS, Weinstock D, Poston ME, Roberts MC. Myeloperoxidase activity of the large intestine in an equine model of acute colitis. Am J Vet Res 1999;60:807–813.
                pubmed: 10407471
              12. Weiss DJ, Evanson OA. Evaluation of activated neutrophils in the blood of horses with colic. Am J Vet Res 2003;64:364–1368.
                pubmed: 14620771
              13. Franck T, Grulke S, Deby-Dupont G. Design and development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. J Vet Diagn Invest 2005;17:412–419.
                pubmed: 16312231
              14. Deby-Dupont G, Grulke S, Caudron I. Equine myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies. Vet Immunol Immunopathol 1998;66:257–271.
                pubmed: 9880103
              15. Grulke S, Benbarek H, Caudron I. Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results. Can J Vet Res 1999;63:142–147.
                pmc: PMC1189534pubmed: 10369573
              16. Yarbrough B, Snyder JR, Harmon FA, O’Connell KA. Evaluation of myeloperoxidase concentrations in experimentally induced equine colonic ischaemia and reperfusion. Equine Vet J 1994;26:67–69.
                pubmed: 8143669
              17. Vandenplas ML, Moore JN, Barton MH, Roussel AJ, Cohen ND. Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic. Am J Vet Res 2005;66:1509–1516.
                pubmed: 16261823
              18. Freden GO, Provost PJ, Rand WM. Reliability of using results of abdominal fluid analysis to determine treatment and predict lesion type and outcome for horses with colic: 218 cases (1991–1994). J Am Vet Med Assoc 1998;213:1012–1015.
                pubmed: 9777000
              19. Matthews S, Dart AJ, Reid SW, Dowling BA, Hodgson DR. Predictive values, sensitivity and specificity of abdominal fluid variables in determining the need for surgery in horses with an acute abdominal crisis. Aust Vet J 2002;80:132–136.
                pubmed: 12019696
              20. Latson KM, Nieto JE, Beldomenico PM, Snyder JR. Evaluation of peritoneal fluid lactate as a marker of intestinal ischaemia in equine colic. Equine Vet J 2005;37:342–346.
                pubmed: 16028624
              21. Little D, Tomlinson JE, Blikslager AT. Post operative neutrophilic inflammation in equine small intestine after manipulation and ischaemia. Equine Vet J 2005;37:329–335.
                pubmed: 16028622
              22. Hurley DH, Parks RJ, Reber AJ. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet Immunol Immunopathol 2006;110:195–206.
                pubmed: 16290066
              23. Riggs LM, Franck T, Moore JN. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract. Am J Vet Res 2007;68:81–86.
                pubmed: 17199423
              24. Tobler A, Koeffler HP. Myeloperoxidase: localization, structure, and function. In: Harris GR, editor. Blood Cell Biochemistry. 3. Lymphocytes and Granulocytes. New York: Plenum Press; 1991. pp. 255–288.
              25. Mathy-Hartert M, Deby-Dupont G, Deby C, Jadoul L, Vandenberghe A, Lamy M. Cytotoxicity induced by neutrophil myeloperoxidase towards human endothelial cells: protection by ceftazidime. Mediators Inflamm 1995;4:1–7.
                pmc: PMC2365676pubmed: 18475677
              26. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992;145:1016–1022.
                pubmed: 1586041
              27. Franck T, Kohnen S, Deby-Dupont G, Grulke S, Deby C, Serteyn D. A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests. J Vet Diagn Invest 2006;18:326–334.
                pubmed: 16921870